Clinical Trials Directory

Trials / Unknown

UnknownNCT01794442

Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins

Correlation Between Retinal Metabolism and the Observation of a Visible Retinal Spontaneous Venous Pulse

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Retinal ischemia is thought to play an important role in the pathogenesis of glaucoma. Recent findings have confirmed that there is a direct correlation between the levels of venous oxygen saturation and the degree of the glaucomatous disease, presumably due to a decrease in retinal cell metabolism. However, glaucoma patients have been suggested to have a different pattern in retinal venous circulation. For instance, the observation of a visible pulsating central retinal vein is a phenomenon that can be seen in up to 98% of the healthy individuals but is identifiable in less than 50% of glaucoma patients. While the nature of these venous changes are not year clear, the lack of a visible pulsating flow could suggest an increased intraluminal venous pressure due to some obstruction from both ocular or extraocular structures. This undetermined increase in venous pulse pressure could then significantly decrease perfusion pressures and therefore further decrease oxygen supply to the retinal tissues. The investigators will therefore try to determine if there is a significant difference between the oxygen saturation of the retinal vessels in both glaucoma patients with and without a visible pulsating central vein

Detailed description

1. Visual field examen will be performed. 2. Structural examination of the optic disc (confocal microscopy) will be performed. 3. Spontaneous venous pulsation will be recorded after a one minute fundoscopy observation. 4. Oximetry reading in the non-contact retinal oximetry of the first 3 order retinal vessels

Conditions

Timeline

Start date
2013-01-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2013-02-18
Last updated
2015-05-29

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01794442. Inclusion in this directory is not an endorsement.